Penn’s one-stop solution for technology commercialization and entrepreneurship
I’m a Faculty Member or Researcher
I’m with a Company
I’m an Entrepreneur
I want to:
Translating Discoveries
PCI helps to translate discoveries and ideas created at the University of Pennsylvania into new products and businesses for societal benefit.
We actively facilitate a broad range of technology development connections between Penn and the private sector. Whether the end result is a technology license, an R&D alliance, or the formation of a new venture, PCI serves as a dedicated one-stop shop for commercial partnering with Penn.
Watch the Recording of “Real World Implementation of AI and Healthcare”
In parallel with the 2025 JP Morgan Healthcare Conference, PCI hosted its annual Innovation @ Penn program in San Francisco on January 13th, 2025. This event was an excellent opportunity to learn about emerging areas of innovation and opportunities for partnership with Penn. The program attracted professionals from across the pharma, MedTech and biotech industries, and investor community, and provided a platform for in-depth discussions about the latest cutting-edge technologies and their practical applications.
We are grateful to our panelists Marylyn Ritchie, PhD, Vice Dean of Artificial Intelligence and Computing, Penn Medicine, David Fajgenbaum, MD, MBA, MSc, Associate Professor of Medicine, Penn Medicine and cofounder of Every Cure and Walter Witschey, PhD, Associate Professor of Radiology, Penn Medicine, for sharing their insights on the impact of AI in healthcare, personal examples of how AI is being used and studied their fields and what’s next for AI in medicine. Thank you to Roy Rosin, MBA, Board Partner, First Round Capital, for serving as moderator for the panel and asking such insightful questions.
Please save the date for next year’s Innovation@Penn program, which will take place on Monday, January 12, 2026 at 3pm.
Penn Startups Raising Capital in 2025
Learn about which Penn startup companies are raising capital in 2025 with this comprehensive list. With companies in connected health, digital health, diagnostics, therapeutics, and medical devices, Penn offers a wide range of rapidly emerging companies at all investment levels.
If you are interested in connecting about these startups, please email Laurie Actman (lactman@upenn.edu).
Download and view the complete list
Available Technologies
Find technology opportunities by sector or search:
Nanotechnology | Antibody | Optics & Photonics | Medical Devices | COVID-19 | Immunology | Oncology | Materials | Bioengineering | Neurodegenerative Diseases
View all technologies
Recent News
All NewsPenn Engineering Welcomes Vanessa Chan as Inaugural Vice Dean of Innovation and Entrepreneurship
Philadelphia’s Biotech Ecosystem Bolstered as WuXi AppTec Deal Eases Congressional Pressure
PCI’s John Swartley Nominated as BioBuzz Leader of the Year Finalist
Berger Lab Makes Discovery Linking cellular structures to kidney cancer treatment outcomes
Read the PCI FY24 Year in Review
1500
Active Commercial Partnership Agreements
150+
Active Penn Spinouts (152)
125
Issued U.S. Patents (+20% from FY23)
#13
Nationally for Utility Patents (NAI Worldwide Universities Granted US Utility Patents)
Discover CAR T-cell technology at Penn
Our latest CAR T-cell enhancement portfolio features innovations poised to transform treatment efficacy with boosted cytokine activity/metabolism, streamlined manufacturing, and reduced T-cell exhaustion. Join us in turning lab discoveries into real-world impact through licensing opportunities with PCI.